medicalnewstoday.com
02.07.2008 06:18
medicalnewstoday.com
Pfizer Animal Health has announced the Food and Drug Administration (FDA) has approved Convenia® (cefovecin sodium), the first and only antibiotic for dogs and cats available in a single veterinarian-administered injectable dose. Convenia provides up to 14 days of antibiotic treatment in a single dose for the most common skin infections in dogs and cats - the No. 1 reason pets are prescribed antibiotics.
World
Veterinary Medicine
02.07.2008 06:18
medicalnewstoday.com
ORLANDO, FL (UroToday.com) - It is recognized that apoptosis is involved in germ cell loss following testicular ischemia-reperfusion (IR) injury. Allopurinol is as a free radical scavenger which prevents tissue damage caused by reperfusion and oxygenation after ischemia. The authors have investigated the ability of allopurinol to effect testicular injury after torsion. Testicular ischemia in rats led to histological damage in the ipsilateral testis.
World
Urology
02.07.2008 06:18
medicalnewstoday.com
ORLANDO, FL (UroToday.com) - Dr. Romero examined the changing trend of bacterial culture isolates associated with renal urinary stones. To examine the current literature on stone culture results, a literature search using the PubMed and Ovid was performed, the results revealed a total of 12 manuscripts from 1984 to 2007 with stone culture data. In the recent literature, the most common bacterial isolates associated with renal urolithiasis were E.
World
Urology
02.07.2008 06:18
medicalnewstoday.com
ORLANDO, FL (UroToday.com) - This study out of Sao Paolo, Brazil showed that shock wave therapy (SWT) can actually induce tissue injury to the tunica albuginea to form a Peyronie's plaque in normal tissue. In a rabbit model, 25 animals were subjected to either SWT, protected SWT (via a rubber barrier), or controls; it was clearly shown that significant tissue trauma is induced during this therapy. Presented by Italo Cortez, MD, et al.
World
Urology
02.07.2008 06:18
medicalnewstoday.com
ORLANDO, FL (UroToday.com) - Dr. Matthias Heck, et al. examined the occurrence of Peyronie's disease (PD) after radical prostatectomy. The incidence of PD in the general population is estimated to be between 3-9%. A retrospective review of 589 patients undergoing radical prostatectomy was performed to examine the incidence of PD in this population with a mean age of 62 years. Results showed that 102/589 developed PD post prostatectomy for an incidence of 17%.
World
Urology
02.07.2008 06:18
medicalnewstoday.com
The House of Lords European Union Committee has welcomed EU proposals for a European directive on the quality and safety of organ donation and transplantation but has stressed that, in establishing minimum standards across Europe, the EU must not impose requirements beyond those which are clinically justifiable. The Committee stress that any directive should include significant flexibility to allow scope for clinical judgement and patient choice.
World
Transplantation
02.07.2008 06:18
medicalnewstoday.com
More people are trying to quit smoking, the air in pubs and bars is cleaner and rates of compliance with smokefree laws remain high, according to a new survey looking at the first year of Smokefree England, published recently. The report Smokefree England: One Year On summarises key findings from businesses, health workers and the public regarding the Smokefree legislation which was introduced one year ago today.
World
Smoking
02.07.2008 06:18
medicalnewstoday.com
When the world's top athletes convene next month for the Beijing 2008 Olympic Games, some will face a challenge that tests more than their athletic abilities. Heavy pollution in the Chinese capital could pose problems for competitors, especially those with asthma, according to the American Academy of Allergy, Asthma & Immunology (AAAAI).
World
Asthma
02.07.2008 06:18
medicalnewstoday.com
Around two in three patients (65 per cent) don't mind which doctor they see if they can get a convenient appointment, according to new Which? research. 67 per cent of patients would be happy to see any doctor if they could easily access their medical records. Although 69 per cent of patients say they would prefer to visit the same doctor each time, only around half of people (52 per cent) who had seen a GP in the last year had seen the same doctor for their last three visits.
World
Critical Care Medicine & Anesthesiology
02.07.2008 06:17
medicalnewstoday.com
The British Society for Antimicrobial Chemotherapy (BSAC) published the first evidence-based UK guidelines to address the management of hospital-acquired pneumonia (HAP) which is the most common hospital acquired infection in intubated1 patients increasing mortality by up to 75%2.
World
Infectious Diseases
02.07.2008 06:17
medicalnewstoday.com
DxS, a personalised medicine company and leaders in the provision of companion diagnostics, has today announced the launch of its K-RAS cancer mutation detection kit in Australia. This follows the kit meeting the compliance standards of Australia's Therapeutic Goods Administration (TGA).
World
Cancer
02.07.2008 06:17
medicalnewstoday.com
Scientists have found that vaccination with a heat-killed, nontoxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice. Vaccination extends overall survival and reduces tumor size in mice that have been injected with cancer cells displaying the same protein that was engineered into the yeast.
World
Cancer
02.07.2008 06:17
medicalnewstoday.com
Thermo Fisher Scientific Inc., the world leader in serving science, believes it has a Thermo Scientific ABgene® PCR plate to fit every major thermal cycler available. This offers the same reliable, reproducible performance in PCR and QPCR applications no matter what cycler is used. Laboratories using multiple cyclers can obtain their plastic PCR consumables from a single, reliable source.
World
Biology
02.07.2008 06:16
medicalnewstoday.com
UCB announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMEA) requesting the approval of Cimzia® (certolizumab pegol) as a subcutaneous treatment for adults with moderate to severe active rheumatoid arthritis (RA) and has been accepted for review. Subject to approval, Cimzia® will be the first and only PEGylated, Fc-Free anti-TNF (Tumour Necrosis Factor alpha) biologic therapy available in Europe for the treatment of RA.
World
Arthritis
02.07.2008 05:17
medicalnewstoday.com
UroToday.com - This study out of Toronto's Hospital for Sick Children evaluated the natural history of complex renal cysts in children. The group identified patients with a known history of a complex renal cyst. To capture the maximum number of patients they searched the database of all radiologic reports from their institution between 1996 and 2004. The group then reviewed the charts of these patients and images to confirm the diagnosis of a complex renal cyst.
World
Children Diseases
English
Українська
Русский
Date: 08 January 2009 - 21:07
Number of sources in English: 130